PT-141 serves as a cutting-edge cyclic melanocortin agonist that demonstrates potential in the treatment of sexual dysfunction. This novel compound functions by activating specific receptors across the body, leading to enhanced sexual function. Preclinical studies have suggested that PT-141 has the potential to remarkably treat a range of sexual d